JBIO Share Price Performance
US$7.29
-2.85 (-28.11%)
Price US$7.29
Share PriceUS$7.29
JBIO Community Narratives
There are no narratives available yet.
Recent JBIO News & Updates
No updates
Jade Biosciences, Inc. Key Details
Last Reported Earnings
Dec 31, 2024
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -2.91
- Gross Margin
- 0%
- Net Profit Margin
- 0%
- Debt/Equity Ratio
- -229.9%
Jade Biosciences, Inc. Competitors
About JBIO
- Founded
- 2024
- Employees
- 30
- CEO
- WebsiteView website
Jade Biosciences, Inc. operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. The company was incorporated in 2024 and is headquartered in Waltham, Massachusetts.
U.S. Market Performance
- 7 Days: -1.2%
- 3 Months: 13.1%
- 1 Year: 22.8%
- Year to Date: 7.3%
Over the last 7 days, the market has dropped 1.2%, driven by a loss of 4.7% in the Consumer Discretionary sector. In contrast to the last week, the market is actually up 23% over the past year. Earnings are forecast to grow by 15% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading